Development and Preclinical Evaluation of a Selinexor-Derived Radiotracer [ 68 Ga]Ga-NOTA-Selinexor for Imaging XPO1 Expression in Multiple Myeloma
Molecular Pharmaceutics · 04.05.2026 · 23 (5) · 2984-2996
DOI: 10.1021/acs.molpharmaceut.5c01792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 02.04.2026. Verfasst von Xinlin Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, P. R. China. Hauptthemen laut MEDLINE: Triazoles, Multiple Myeloma, Hydrazines, Karyopherins. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Basic Research Program of Jiangsu Province, National Natural Science Foundation of China, Project of Jiangsu Provincial Health and Wellness Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, P. R. China.
- NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, P. R. China.
- School of Chemical and Material Engineering, Jiangnan University, Wuxi 214122, P. R. China.
- Affiliated Women's Hospital of Jiangnan University, Jiangnan University, Wuxi 214002, P. R. China.
ORCID-Profile: Junjie Yan, Xinyu Wang, Min Yang
Förderung
- Basic Research Program of Jiangsu Province
- National Natural Science Foundation of China
- Project of Jiangsu Provincial Health and Wellness Commission
- Jiangsu Provincial Medical Key Laboratory
Zitieren
APA
Zhong, X., Yan, J., Su, C., Xu, W., Wang, X., Pan, D., Xu, Y., Wang, L., Chen, C., & Yang, M. (2026). Development and Preclinical Evaluation of a Selinexor-Derived Radiotracer [ 68 Ga]Ga-NOTA-Selinexor for Imaging XPO1 Expression in Multiple Myeloma. Molecular Pharmaceutics, 23(5), 2984-2996. https://doi.org/10.1021/acs.molpharmaceut.5c01792
Vancouver
Zhong X, Yan J, Su C, Xu W, Wang X, Pan D, et al. Development and Preclinical Evaluation of a Selinexor-Derived Radiotracer [ 68 Ga]Ga-NOTA-Selinexor for Imaging XPO1 Expression in Multiple Myeloma. Molecular Pharmaceutics. 2026;23(5):2984-2996. doi:10.1021/acs.molpharmaceut.5c01792
BibTeX
@article{Zhong2026,
author = {Zhong, Xinlin and Yan, Junjie and Su, Chen and Xu, Wei and Wang, Xinyu and Pan, Donghui and Xu, Yuping and Wang, Lizhen and Chen, Chongyang and Yang, Min},
title = {Development and Preclinical Evaluation of a Selinexor-Derived Radiotracer [ 68 Ga]Ga-NOTA-Selinexor for Imaging XPO1 Expression in Multiple Myeloma},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {5},
pages = {2984--2996},
doi = {10.1021/acs.molpharmaceut.5c01792}
}
EUVIMED